As an important active component of human thymus hormone, Thymopentin is artificially synthesized and free of allergenic protein and reaction, which significantly enhances the effect of Thymopentin as a substitute for thymosin injections. Therefore, Thymopentin is a strong performer among thymosin drugs.
In 1985, Thymopentin for Injection was launched in Italy in the trade name of "Timunox". In 1997, Hainan Zhonghe Pharmaceutical Co., Ltd. first launched Thymopentin for Injection (trade name: Hexin), China's first two-way immunomodulator of synthetic polypeptide after independent research and development. The product once played an important role in the fight against SARS in 2003. Later, other enterprises including Beijing SL Pharmaceutical Co., Ltd. were approved to produce Thymopentin. Because of a low technological barrier, there are many manufacturers and fierce competitions in the market. Thymopentin is only sold in China as a Chinese-style drug.
According to the researcher, in 2017, the sales value of Thymopentin exceeded CNY 1 billion in the Chinese market dominated by Hainan Zhonghe Pharmaceutical Co., Ltd., Beijing SL Pharmaceutical Co., Ltd., Beijing Sciecure Pharmaceutical Co., Ltd. and Hybio Pharmaceutical Co., Ltd. The sales value of top 10 enterprises took up about 99% of the market. The sales value of Hainan Zhonghe ranked first with a market share over 30%. It is expected that the Chinese Thymopentin still has large potential to grow in the coming years.
Topics Covered:
- Development of Chinese Thymopentin Market
- Size of Chinese Thymopentin Market
- Competition Pattern of Chinese Thymopentin Market
- Thymopentin Prices in Chinese Thymopentin Market
- Prospects of Chinese Thymopentin Market
Table of Contents
Samples
LOADING...
Companies Mentioned
- Beijing SL Pharmaceutical Co., Ltd.
- Beijing Sciecure Pharmaceutical Co., Ltd.
- Chengdu DIAO Jiuhong Pharmaceutical Factory
- Hainan Zhonghe Pharmaceutical Co., Ltd.
- Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.
- Hybio Pharmaceutical Co., Ltd.
- Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd.
- Sinopharm A-Think Pharmaceutical Co., Ltd.
- Wuhan Hualong Bio-pharmaceutical Co., Ltd.
- Yangtze River Pharmaceutical (Group) Co., Ltd.
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
